Get the Stockscreener App
8.94
1.19%
0.105
Pre-market:
9.08
0.14
+1.57%
Clearpoint Neuro Inc stock is traded at $8.94, with a volume of 1.22M.
It is up +1.19% in the last 24 hours and down -32.83% over the past month.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
See More
Previous Close:
$8.835
Open:
$8.98
24h Volume:
1.22M
Relative Volume:
1.64
Market Cap:
$265.95M
Revenue:
$34.33M
Net Income/Loss:
$-23.14M
P/E Ratio:
-10.82
EPS:
-0.8262
Net Cash Flow:
$-13.82M
1W Performance:
-41.03%
1M Performance:
-32.83%
6M Performance:
-19.31%
1Y Performance:
-33.33%
1-Day Range:
$8.63
$9.20
1-Week Range:
$8.63
$15.00
52-Week Range:
$8.63
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
8.94 | 262.83M | 34.33M | -23.14M | -13.82M | -0.8262 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Journey Medical Corp (DERM) - The Globe and Mail
CLPT Technical Analysis & ETF Price Forecast - Intellectia AI
CLPT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
(CLPT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
CEO-related trust at ClearPoint Neuro (CLPT) sells 19,951 shares under plan - Stock Titan
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Uncovering a Potential 91% Upside in the Medical Device Sector - DirectorsTalk Interviews
VIX Spike: Can ClearPoint Neuro Inc reach all time highs this yearEntry Point & Intraday High Probability Alerts - baoquankhu1.vn
CLPT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CLPT (NASDAQ: CLPT) Rule 144 filing lists vested RSAs/RSUs; January 10b5-1 sales - Stock Titan
CLS Q4 (Review): Low sales due to alignment discussions with ClearPoint Neuro - marketscreener.com
CLPTClearpoint Neuro Inc Latest Stock News & Market Updates - Stock Titan
Will ClearPoint Neuro Inc. be affected by tariffs2025 Retail Activity & Technical Buy Zone Confirmation - mfd.ru
Clearpoint Neuro Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
CLPT (NASDAQ: CLPT) amendment lists 10b5-1 sale of 26,463 shares - Stock Titan
Published on: 2026-02-20 20:00:43 - baoquankhu1.vn
ClearPoint Neuro (CLPT) awards 147,275 restricted stock units to CEO Burnett - Stock Titan
ClearPoint Neuro (CLPT) to Release Earnings on Wednesday - MarketBeat
Responsive Playbooks and the CLPT Inflection - Stock Traders Daily
Will ClearPoint Neuro Inc. stock continue upward momentumJuly 2025 PreEarnings & Risk Managed Investment Strategies - mfd.ru
Is ClearPoint Neuro Inc. stock ready for breakout2025 Bull vs Bear & Free Accurate Trade Setup Notifications - mfd.ru
Pullback Watch: What are ClearPoint Neuro Incs recent SEC filings showing2025 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
ClearPoint Neuro Inc. (CLPT): Investor Outlook Reveals 116.90% Potential Upside In Medical Devices Sector - DirectorsTalk Interviews
Is ClearPoint Neuro Inc. stock forming a cup and handle2025 Trade Ideas & Weekly Market Pulse Updates - mfd.ru
ClearPoint Neuro shares advance after securing EU MDR approval - MSN
Essex Investment Management Co. LLC Sells 92,920 Shares of ClearPoint Neuro, Inc. $CLPT - MarketBeat
Published on: 2026-02-07 14:18:50 - baoquankhu1.vn
Aug Big Picture: What chart patterns are forming on Cavco Industries IncDividend Hike & Growth Focused Entry Reports - baoquankhu1.vn
Earnings Risk: What is GCTSWSs valuation compared to sectorQuarterly Growth Report & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Understanding the Setup: (CLPT) and Scalable Risk - Stock Traders Daily
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a 117.88% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
US Market Wrap: What are ClearPoint Neuro Incs recent SEC filings showingQuarterly Trade Review & Growth Focused Entry Point Reports - baoquankhu1.vn
ClearPoint Neuro expands team to over 170 focused on Neuro - Traders Union
Painful Week for Individual Investors Invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) After 18% Drop, Institutions Also Suffered Losses - 富途牛牛
ClearPoint Neuro (NASDAQ:CLPT shareholders incur further losses as stock declines 18% this week, taking five-year losses to 47% - simplywall.st
Published on: 2026-01-30 00:59:02 - baoquankhu1.vn
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Is A 115.93% Upside On The Horizon? - DirectorsTalk Interviews
Insider Selling: ClearPoint Neuro (NASDAQ:CLPT) CEO Sells $45,822.51 in Stock - MarketBeat
CLPT Gets EU MDR Certification for ClearPoint Navigation Software - Finviz
ClearPoint Neuro: From Validation To Scale (NASDAQ:CLPT) - Seeking Alpha
Market Review: Can NextPlat Corp Equity Warrant outperform under higher oil pricesRisk Management & Growth Focused Investment Plans - baoquankhu1.vn
Quarterly Earnings: Will Georgia Power Company Preferred Security be affected by tariffsBreakout Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
The Technical Signals Behind (CLPT) That Institutions Follow - Stock Traders Daily
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software - Sahm
ClearPoint Neuro receives EU MDR certification for navigation software By Investing.com - Investing.com Australia
ClearPoint Neuro stock rises after receiving EU MDR certification By Investing.com - Investing.com South Africa
ClearPoint Neuro stock rises after receiving EU MDR certification - Investing.com
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe - BioSpace
ClearPoint Neuro receives EU MDR certification for navigation software - Investing.com
New brain surgery software opens CT-guided option for hospitals without MRI - Stock Titan
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Navigating a 107% Potential Upside with Analyst Confidence - DirectorsTalk Interviews
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):